66 results
6-K
EX-99.2
6y4hbg35
5 Dec 23
Current report (foreign)
8:50am
6-K
EX-99.2
hx7zcx edzo7b5
21 Sep 23
Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates
10:52am
6-K
jtz3xopth1ypue82am
30 Sep 22
Valneva Announces the Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares
4:22pm
6-K
EX-1.1
c5ef1u6epg 35e
30 Sep 22
Valneva Announces the Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares
4:22pm
424B5
6jlbsj1x 9493je
30 Sep 22
Prospectus supplement for primary offering
4:09pm
424B5
dufhdm
28 Sep 22
Prospectus supplement for primary offering
8:24pm
6-K
EX-99.2
pco63i8
8 Sep 22
Valneva Announces Publication of its COVID-19 Vaccine Phase 3 Data in The Lancet Infectious Diseases
3:39pm
6-K
EX-99.1
i27yrz
29 Aug 22
Current report (foreign)
5:00pm
6-K
EX-10.1
klw7qnj
15 Aug 22
Report of Foreign Private Issuer
9:20am
6-K
EX-10.3
lcfc3i1sm0hzvdj4d0st
15 Aug 22
Report of Foreign Private Issuer
9:20am
6-K
EX-10.6
zcjqsrx4qi7dj7
15 Aug 22
Report of Foreign Private Issuer
9:20am